Structure-Based Design and Molecular Docking Analysis of Uridine-Based and Muraymycin C2 Inhibitors Targeting MraY Translocase in Clinical Isolates Pseudomonas aeruginosa Molecular Docking Analysis
01Abstract
Background: Multidrug resistance (MDR) Pseudomonas aeruginosa has become a major clinical problem because of its resistance to a variety of antibiotic classes and the limited number of effective therapy options. Objectives: This study was to perform structure-based design, molecular docking and molecular characterization of Uridine-based and Liponucleoside derivatives of essential translocase in MDR P. aeruginosa (MraY). Results : An antimicrobial resistance profile of (44) forty-four isolates of P. aeruginosa revealed high levels of resistance to, cefotaxime, amoxicillin-clavulanic acid and trimethoprim-sulfamethoxazole (100%), and 60% of strains were resistant to the carbapenems. All the clinical isolates were positive results in PCR for the presence of MraY gene, its conserved a widespread distribution, and therapeutic importance. Cavity detection and virtual screening in five possible binding pockets resulted in Cavity1 (C1) having a volume of 1819 Å3 at the coordinates (-20, -1, 14) being the main catalytic active site. The natural reference inhibitor Muraymycin C2 showed a high binding interaction of -9.6 kcal/mol within the C1, with significant interactions with the residue ASP115, ASP116, SER120 and THR73. While, the candidate ligand, Uridine 5ˈ-monophosphate, showed a stable and consistent binding score of (-7.6 kcal /mol) in C1, with supporting hydrogen bonds with ALA56, ASP116 and THR71.
ADMET and toxicological profiling indicated that Uridine 5ˈ-monophosphate possesses a favorable molecular weight (324.18 g/mol) and compliance with drug-like properties, while both evaluated ligands exhibited exceptionally clean safety profiles, showing no mutagenicity (AMES), hepatotoxicity, cardiotoxicity (hERG) or skin sensitization risks. Conclusions: The findings highlight that while Muraymycin C2 serves as a high-affinity natural benchmark, the uridine-based scaffold provides a non-toxic and chemically tractable framework for future lead optimization against MDR P. aeruginosa.
Keywords: Uridine 5ˈ-monophosphate, MraY translocase, Clinical isolates Multidrug-resistant Pseudomonas aeruginosa, ADMET profiling, Muraymycin C2, Structural-based drug design, Molecular docking.
02Authors
03Article Details
- Section
- Articles Publishing terms and rules
- Pages
- 1-28
- Published
- 2026-10-31
- License
-

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
04References
- 1- Avakh, A., Grant, G. D., Cheesman, M. J., Kalkundri, T., & Hall, S. (2023). The Art of War with Pseudomonas aeruginosa: Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy. Antibiotics (Basel, Switzerland), 12(8), 1304. https://doi.org/10.3390/antibiotics12081304
- 2- Abdallah, E. M., Alhudhaibi, A. M., Dahab, M., Al Noman, A., Sharma, P. D., Taha, T. H., & Nawaz, M. (2026). The WHO priority list of antibiotic-resistant bacteria: Challenges and opportunities for next-generation antimicrobial development. Frontiers in Pharmacology, 17, 1699987. https://doi.org/10.3389/fphar.2026.1699987
- 3- Pang, Z., Raudonis, R., Glick, B. R., Lin, T. J., & Cheng, Z. (2019). Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnology advances, 37(1), 177–192. https://doi.org/10.1016/j.biotechadv.2018.11.013
- 4- Breidenstein, E. B., de la Fuente-Núñez, C., & Hancock, R. E. (2011). Pseudomonas aeruginosa: all roads lead to resistance. Trends in microbiology, 19(8), 419–426. https://doi.org/10.1016/j.tim.2011.04.005
- 5- Chung, B. C., Zhao, J., Gillespie, R. A., Kwon, D. Y., Guan, Z., Hong, J., Zhou, P., & Lee, S. Y. (2013). Crystal Structure of MraY, an Essential Membrane Enzyme for Bacterial Cell Wall Synthesis. Science (New York, N.Y.), 341(6149), 1012. https://doi.org/10.1126/science.1236501
- 6- Mashalidis, E. H., Kaeser, B., Terasawa, Y., Katsuyama, A., Kwon, D. Y., Lee, K., Hong, J., Ichikawa, S., & Lee, S. Y. (2019). Chemical logic of MraY inhibition by antibacterial nucleoside natural products. Nature Communications, 10(1), 2917. https://doi.org/10.1038/s41467-019-10957-9
- 7- Gervasoni, S.; Malloci, G.; Bosin, A.; Vargiu, A.V.; Zgurskaya, H.I.; Ruggerone, P. Recognition of quinolone antibiotics by the multidrug efflux transporter MexB of Pseudomonas aeruginosa. Phys. Chem. Chem. Phys. 2022, 24, 16566–16575. DOI: https://doi.org/10.1039/d2cp00951j
- 8- Phan, T. V., Nguyen, V. T., Le, M. T., Nguyen, B. G. D., Vu, T. T., & Thai, K. M. (2024). Identification of efflux pump inhibitors for Pseudomonas aeruginosa MexAB-OprM via ligand-based pharmacophores, 2D-QSAR, molecular docking, and molecular dynamics approaches. Molecular diversity, 28(5), 3295–3311. https://doi.org/10.1007/s11030-023-10758-9
- 9- Dey D, Kavanaugh LG, Conn GL2020.Antibiotic Substrate Selectivity of Pseudomonas aeruginosa MexY and MexB Efflux Systems Is Determined by a Goldilocks Affinity. Antimicrob Agents Chemother64:10.1128/aac.00496-20. https://doi.org/10.1128/aac.00496-20
- 10- Babalola, B. A., Malik, M., Olowokere, O., Adebesin, A., & Sharma, L. (2025). Indoles in drug design and medicinal chemistry. European Journal of Medicinal Chemistry Reports, 13, 100252. https://doi.org/10.1016/j.ejmcr.2025.100252
- 11- Schuetz, A. N., Ferrell, A., Hindler, J. A., Humphries, R., & Bobenchik, A. M. (2025). Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions. Journal of Clinical Microbiology, 63(9), e01623-23. https://doi.org/10.1128/jcm.01623-23
- 12- Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic acids research, 46(W1), W296–W303. https://doi.org/10.1093/nar/gky427
- 13- Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., Zaslavsky, L., Zhang, J., & Bolton, E. E. (2023). PubChem 2023 update. Nucleic acids research, 51(D1), D1373–D1380. https://doi.org/10.1093/nar/gkac956
- 14- Liu, Y., Yang, X., Gan, J., Chen, S., Xiao, Z. X., & Cao, Y. (2022). CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic acids research, 50(W1), W159–W164. https://doi.org/10.1093/nar/gkac394
- 15- Yang, X., Liu, Y., Gan, J., Xiao, Z. X., & Cao, Y. (2022). FitDock: protein-ligand docking by template fitting. Briefings in bioinformatics, 23(3), bbac087. https://doi.org/10.1093/bib/bbac087
- 16- Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717. https://doi.org/10.1038/srep42717
- 17- Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. Journal of medicinal chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
- 18- IBM Corp (2022). IBM SPSS Statistics for Windows (29). versions 29, 29.0.1. https://www.ibm.com/docs/en/spss-statistics/29.0.0?topic=overview-whats-new-in-versions-29-2901
- 19- McHugh, M. L. (2013). The Chi-square test of independence. Biochemia Medica, 23(2), 143. https://doi.org/10.11613/BM.2013.018
- 20- Hu, M., & Chua, S. L. (2025). Antibiotic-Resistant Pseudomonas aeruginosa: Current Challenges and Emerging Alternative Therapies. Microorganisms, 13(4), 913. https://doi.org/10.3390/microorganisms13040913
- 21- Yin, C., Alam, M. Z., Fallon, J. T., & Huang, W. (2024). Advances in Development of Novel Therapeutic Strategies against Multi-Drug Resistant Pseudomonas aeruginosa. Antibiotics, 13(2), 119. https://doi.org/10.3390/antibiotics13020119
- 22- Bertoni, M., Kiefer, F., Biasini, M., Bordoli, L., & Schwede, T. (2017). Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology. Scientific reports, 7(1), 10480. https://doi.org/10.1038/s41598-017-09654-8
- 23- Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., Jain, S., Lewis, S. M., Arendall, W. B., 3rd, Snoeyink, J., Adams, P. D., Lovell, S. C., Richardson, J. S., & Richardson, D. C. (2018). MolProbity: More and better reference data for improved all-atom structure validation. Protein science : a publication of the Protein Society, 27(1), 293–315. https://doi.org/10.1002/pro.3330
- 24- Alharbi, M. S., Moursi, S. A., Alshammari, A., Aboras, R., Rakha, E., Hossain, A., Alshubrumi, S., Alnazha, K., Khaja, A. S. S., & Saleem, M. (2025). Multidrug-resistant Pseudomonas aeruginosa: Pathogenesis, resistance mechanisms, and novel therapeutic strategies. Virulence, 16(1), 2580160. https://doi.org/10.1080/21505594.2025.2580160
- 25- Dash, S., Sharma, A., & Kini, S. G. (2026). MraY: An emerging therapeutic target in bacterial peptidoglycan biosynthesis for the discovery of novel antibiotics from natural and synthetic origin. European journal of medicinal chemistry, 301, 118234. https://doi.org/10.1016/j.ejmech.2025.118234
- 26- Jimenez, D. G., Poongavanam, V., & Kihlberg, J. (2023). Macrocycles in Drug Discovery—Learning from the Past for the Future. Journal of Medicinal Chemistry, 66(8), 5377. https://doi.org/10.1021/acs.jmedchem.3c00134
- 27- Amrhein, J. A., Knapp, S., & Hanke, T. (2021). Synthetic Opportunities and Challenges for Macrocyclic Kinase Inhibitors. Journal of medicinal chemistry, 64(12), 7991–8009. https://doi.org/10.1021/acs.jmedchem.1c00217
- 28- Ríos-Rozas, S. E., Valdés-Muñoz, E., Rojas-Santander, V., Farías-Abarca, J., Hernández-Rodríguez, E. W., Contreras, H. R., Palma, J. M., Suardíaz, R., Osorio, M. I., Yáñez, O., Morales-Quintana, L., & Bustos, D. (2026). Drug Repurposing Uncovers New Chemical Scaffolds as Potent Urease Inhibitors: A Comprehensive Computational Study. International Journal of Molecular Sciences, 27(8), 3561. https://doi.org/10.3390/ijms27083561
